Kringle Pharma Inc (4884 JP): Full-year FY09/25 flash update
FY09/25 revenue was JPY72mn, with a net loss of JPY916mn, primarily from technology access fees from Claris Biotherapeutics. FY09/26 forecasts...
93 Views
Kringle Pharma Inc (4884 JP): Q3 FY09/25 flash update
Revenue and gross profit for cumulative Q3 FY09/25 were JPY54mn, down 12.4% YoY, with SG&A expenses up 23.6%. Operating, recurring, and net...
305 Views
Kringle Pharma Inc (4884 JP): 1H FY09/25 flash update
Revenue and gross profit for 1H FY09/25 were JPY36mn, down 16.5% YoY, with SG&A expenses up 33.7%. Current assets decreased by JPY491mn,...
237 Views
Kringle Pharma Inc (4884 JP): Full-year FY09/24 flash update
FY09/24 results: Revenue JPY80mn (+15.6% YoY), operating loss JPY818mn, net loss JPY756mn, SG&A expenses JPY898mn. FY09/25 forecast: Revenue...
265 Views
Kringle Pharma Inc (4884 JP): Q3 FY09/24 flash update
**Q3 FY09/24 Financial Results:** Revenue JPY61mn (+19.3% YoY), operating loss JPY580mn, net loss JPY518mn, total assets JPY2.9bn. **Revised...
276 Views
No more insights